Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2012  |  Volume : 8  |  Issue : 3  |  Page : 343-347

Personalized medicine of esophageal cancer

1 Department of Cardiothoracic Surgery, Hebei Medical University Fourth Hospital, ShiJiaZhuang, Hebei, China
2 SurExam Bio Tech Co. Ltd., Guangzhou Technology Innovation Base, Science City, Guangzhou, China

Correspondence Address:
Yong-Qing Zheng
SurExam Bio Tech Co. Ltd., Guangzhou Technology Innovation Base, Science City, Guangzhou
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0973-1482.103510

Rights and Permissions

The fatality rate of esophageal carcinomas is high in developing countries, making effective treatment desirable. Traditional treatment has now entered into the platform, and treatments based on the detection of biomarkers increasingly become a trend. This review presents several biomarkers of esophageal cancer, including chemotherapy-related biomarkers and targeted drug-related biomarkers, and the correlation of these biomarkers with drug response.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded458    
    Comments [Add]    
    Cited by others 2    

Recommend this journal